Log in to save to my catalogue

Defining SOD1 ALS natural history to guide therapeutic clinical trial design

Defining SOD1 ALS natural history to guide therapeutic clinical trial design

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5136332

Defining SOD1 ALS natural history to guide therapeutic clinical trial design

About this item

Full title

Defining SOD1 ALS natural history to guide therapeutic clinical trial design

Publisher

England: BMJ Publishing Group LTD

Journal title

Journal of neurology, neurosurgery and psychiatry, 2017-02, Vol.88 (2), p.99-105

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

ImportanceUnderstanding the natural history of familial amyotrophic lateral sclerosis (ALS) caused by SOD1 mutations (ALSSOD1) will provide key information for optimising clinical trials in this patient population.ObjectiveTo establish an updated natural history of ALSSOD1.Design, setting and participantsRetrospective cohort study from 15 medical c...

Alternative Titles

Full title

Defining SOD1 ALS natural history to guide therapeutic clinical trial design

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5136332

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5136332

Other Identifiers

ISSN

0022-3050

E-ISSN

1468-330X

DOI

10.1136/jnnp-2016-313521

How to access this item